4-Aminobiphenyl-DNA adducts and p53 mutations in bladder cancer

Int J Cancer. 1998 Feb 9;75(4):512-6. doi: 10.1002/(sici)1097-0215(19980209)75:4<512::aid-ijc4>3.0.co;2-w.

Abstract

Epidemiologic studies have suggested that smokers of air-cured tobacco (rich in arylamines) are at higher risk of bladder cancer than smokers of flue-cured tobacco. The risk has been shown to be modulated by the N-acetyltransferase genotype. We analyzed the biopsies of 45 patients with bladder cancer. p53 mutations were sought by direct sequencing, and 4-aminobiphenyl-DNA adducts were measured by negative ion gas chromatography-mass spectrometry. 4-Aminobiphenyl-DNA adducts were higher in smokers of air-cured tobacco and in current smokers, but no relationship with the number of cigarettes smoked was found. Adducts were higher in more advanced histologic grades of tumors. No pattern was evident for p53 mutations. Seven of 9 mutations occurred in grade 3 tumors. No association was found between 4-ABP adducts and GSTM1 or NAT2 genetic polymorphisms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aminobiphenyl Compounds / metabolism*
  • Arylamine N-Acetyltransferase / physiology
  • DNA Adducts*
  • Genes, p53*
  • Glutathione Transferase / physiology
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Plants, Toxic
  • Smoking*
  • Tobacco
  • Urinary Bladder Neoplasms / genetics*

Substances

  • Aminobiphenyl Compounds
  • DNA Adducts
  • Arylamine N-Acetyltransferase
  • NAT2 protein, human
  • Glutathione Transferase